Overview

Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Status:
RECRUITING
Trial end date:
2031-03-30
Target enrollment:
Participant gender:
Summary
This study is being conducted to study how nirogacestat may affect the ovarian function of adult premenopausal women with progressing desmoid tumors/aggressive fibromatosis.
Phase:
PHASE4
Details
Lead Sponsor:
SpringWorks Therapeutics, Inc.
Treatments:
nirogacestat